WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first donor kidney ...
WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first-in-human cases ...
ANDOVER, Mass., Aug. 2, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...
27 April 2025, Boston—In places like Australia, where metropolitan areas are separated by an entire continent, donor hearts used to go unused simply because transplant teams couldn’t get the organ to ...
Continuous bioprocessing PAT requires real-time sensors and closed-loop control to maintain steady-state culture conditions.
Gene editing donor organs during machine perfusion could rescue more than 28,000 organs discarded annually in the US, per a ...
New Modes Are Beginning to Gain Ground on Fed-batch Strategy The therapeutic success of highly efficacious complex biologicals that are almost exclusively produced in cell culture such as antibodies ...
PLYMOUTH, Mich., Feb. 20, 2026 /PRNewswire/ -- Orrum Clinical Analytics today announced a strategic partnership with LivaNova USA Inc. to connect LivaNova's Essenz™ Perfusion System to the analytics ...
CT:VQ™ gives physicians access to ventilation and perfusion imaging and data derived directly from routine, non-contrast, ...
FUJIFILM Biosciences, announced the commercial launch of BalanCD HEK293 Perfusion A. Designed to expand and augment the company’s portfolio of gene therapy application solutions, BalanCD HEK293 ...
FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results